心肌灌注显像确定的完全血运重建较不完全血运重建和未血运重建可改善稳定性冠心病患者结局
该回顾性随访研究纳入286例连续接受临床负荷-静息SPECT心肌灌注显像的患者,比较完全血运重建、不完全血运重建和未血运重建三组结局,并按缺血程度(<10%与≥10%缺血心肌)分层。中位随访46±21个月,完全血运重建组死亡和MACE均优于不完全血运重建和未血运重建组,尤其在≥10%缺血心肌患者中;轻度缺血患者三组结局无显著差异。
要点
- 完全血运重建组死亡和MACE均优于不完全血运重建和未血运重建组,尤其在≥10%缺血心肌患者中。
- 轻度缺血(<10%缺血心肌)患者中,完全血运重建、不完全血运重建和未血运重建三组结局无显著差异。
- 血运重建组MACE显著低于未血运重建组(P<.001),但死亡率无显著差异(P=.158)。
核心结论
- 完全血运重建患者的结局最可能优于不完全血运重建和未血运重建,尤其当患者缺血心肌超过10%时。
研究设计与样本
- 回顾性随访研究,连续纳入286例接受临床负荷-静息SPECT心肌灌注显像的患者,按治疗方式分为完全血运重建、不完全血运重建和未血运重建三组,并按缺血程度(<10%与≥10%缺血心肌)分为两个亚组。
主要发现
- 286例患者随访46±21个月,记录30例死亡和65例MACE。
- 血运重建组MACE显著低于未血运重建组(P<.001),但死亡率无显著差异(P=.158)。
- 完全血运重建组死亡结局优于不完全血运重建和未血运重建组(死亡:P=.019;MACE:P<.001)。
- 在≥10%缺血心肌患者中,完全血运重建组结局优于不完全血运重建和未血运重建组(死亡:P=.034;MACE:P<.001)。
- 在<10%缺血心肌患者中,完全血运重建、不完全血运重建和未血运重建三组结局无显著差异(P>.05)。
关键数值与推荐
- 缺血程度分层阈值:轻度缺血为<10%缺血心肌,中重度缺血为≥10%缺血心肌。
- 主要终点为全因死亡,次要终点为死亡、非致死性心肌梗死和再次血运重建的复合终点(MACE)。
临床怎么用
- 原文结论认为完全血运重建患者的结局最可能优于不完全血运重建和未血运重建,尤其当患者缺血心肌超过10%时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the outcomes among patients treated by complete coronary revascularization (CCR) or incomplete coronary revascularization (ICR) and no coronary revascularization (NCR) by myocardial perfusion imaging (MPI), as well as to evaluate the impact of severity of ischemia on patients with coronary artery disease (CAD) by different therapy strategies. BACKGROUND: Using myocardial ischemia severity determined by MPI guiding treatment strategies for CAD patients still lacks strong clinical evidences. METHODS: Consecutive patients (N = 286) underwent clinical stress-rest SPECT MPI and were retrospectively followed-up. For assessment of outcome of treatment, all patients were classified into three groups (CCR, ICR, and NCR), and further divided into two subgroups as mild ischemia (< 10% ischemic myocardium) and moderate-severe ischemia (≥ 10% ischemic myocardium). All-cause death was defined as the primary endpoint, and the composite of deaths, nonfatal myocardial infarction, and repeat revascularization (MACE) as the secondary endpoint. RESULTS: Two-hundred eighty-six patients were followed-up for 46 ± 21 months. Thirty deaths and 65 MACEs were recorded. Patients treated by revascularization had significantly lower MACE (P < .001) but not mortality (P = .158) than patients treated by NCR. Outcomes of CCR related to mortality rate were greater than ICR and NCR (death: P = .019, MACE: P < .001). In patients with moderate-severe ischemia, CCR showed improved outcomes than ICR and NCR (death: P = .034; and MACE: P < .001). In patients with mild ischemia, the outcomes of CCR, ICR, and NCR had no significant difference (P > .05). Multivariate regression Cox analysis revealed that summed difference score [death: HR 1.09 (1.03, 1.15), P = .004] was an independent risk factor and CCR was an independent negative predictor [death: HR 0.31 (0.12, 0.81), P = .017; MACE: HR 0.30 (0.16, 0.57), P < .001]. CONCLUSIONS: Outcomes of patients treated by CCR were most likely more promising in comparison with treatment of ICR and NCR, especially when patients had over 10% ischemic myocardium.
引用
- Li J, Yang X, Tian Y, et al. Complete revascularization determined by myocardial perfusion imaging could improve the outcomes of patients with stable coronary artery disease, compared with incomplete revascularization and no revascularization. J Nucl Cardiol. 2017. PMID: 29214612. doi:10.1007/s12350-017-1145-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。